Journal: Cell Reports
Article Title: Phospho-Ser 784 -VCP Is Required for DNA Damage Response and Is Associated with Poor Prognosis of Chemotherapy-Treated Breast Cancer
doi: 10.1016/j.celrep.2020.107745
Figure Lengend Snippet:
Article Snippet: Commercial antibodies used for western blot include GFP (CST, #2956), VCP (Santa Cruz, sc-57492 and sc-136273), actin (Santa Cruz, sc-47778), GAPDH (Santa Cruz, sc-365062), histone H3 (CST, #4499), tubulin (Sigma, T9026), PELP1 (Bethyl, #A300-180A), γH2AX (CST, #9718), Ku70 (Santa Cruz, sc-17789), ATM (Santa Cruz, sc-377293), pSer 1981 -ATM (CST, #5883; Rockland, #200-301-400), pSer 428 -ATR (CST, #2853), ATR (CST, #13934), Chk2 (CST, #3440), pThr 68 -Chk2 (CST, #2197), pSer 345 -Chk1 (CST, #2348), NBS1 (CST, #14956), pSer 343 -NBS1 (CST, #3011), K48-ubiquitin (CST, #4289; CST, #8081), FLAG tag (BioLegend, #637301), NPL4 (Bethyl, #A304-102A), UFD1 (Bethyl, #A301-875A), CHOP (CST, #2895), BiP (CST, #3177), phospho-ATM/ATR substrate motif (CST, #6966), Pfn1 (CST, #3246), HIF1α (CST, #79233).
Techniques: Recombinant, Single Cell Gel Electrophoresis, Plasmid Preparation, Software, Lysis